Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Horowitz

Showing results (531-540 of 599) with videos related to

Pageof 60
Sort By:
European Journal of Heart Failure|March 12, 2004
Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failureR A Anderson, G R Ellis, Y Y Chirkov, et al.
Journal of the American College of Cardiology|September 29, 2012
Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trialSimon Stewart, Melinda J Carrington, Thomas H Marwick, et al.
American Journal of Cardiovascular Disease|August 27, 2015
Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED scoreNathan Ek Procter, Jocasta Ball, Tamila Heresztyn, et al.
British Journal of Pharmacology|April 2, 2022
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistanceAnida Velagic, Jasmin Chendi Li, Cheng Xue Qin, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteersG A Thompson, J V St Peter, M A Heise, et al.
Circulation|October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialLars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
American Journal of Surgery|August 1, 1993
Magnetic resonance angiography in the preoperative evaluation of abdominal aortic aneurysmsJ R Durham, C A Hackworth, J C Tober, et al.
Frontiers in Psychiatry|May 2, 2022
Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility TrialPhillip J Tully, Deborah A Turnbull, John D Horowitz, et al.
Lancet (London, England)|December 4, 2014
Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trialSimon Stewart, Jocasta Ball, John D Horowitz, et al.
Nitric Oxide : Biology and Chemistry|July 12, 2011
Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin DD T M Ngo, W P Chan, S Rajendran, et al.
Pageof 60

Showing results (531-540 of 599) with videos related to

Sort By:
Pageof 60
European Journal of Heart Failure|March 12, 2004
Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failureR A Anderson, G R Ellis, Y Y Chirkov, et al.
Journal of the American College of Cardiology|September 29, 2012
Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trialSimon Stewart, Melinda J Carrington, Thomas H Marwick, et al.
American Journal of Cardiovascular Disease|August 27, 2015
Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED scoreNathan Ek Procter, Jocasta Ball, Tamila Heresztyn, et al.
British Journal of Pharmacology|April 2, 2022
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistanceAnida Velagic, Jasmin Chendi Li, Cheng Xue Qin, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteersG A Thompson, J V St Peter, M A Heise, et al.
Circulation|October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialLars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
American Journal of Surgery|August 1, 1993
Magnetic resonance angiography in the preoperative evaluation of abdominal aortic aneurysmsJ R Durham, C A Hackworth, J C Tober, et al.
Frontiers in Psychiatry|May 2, 2022
Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility TrialPhillip J Tully, Deborah A Turnbull, John D Horowitz, et al.
Lancet (London, England)|December 4, 2014
Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trialSimon Stewart, Jocasta Ball, John D Horowitz, et al.
Nitric Oxide : Biology and Chemistry|July 12, 2011
Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin DD T M Ngo, W P Chan, S Rajendran, et al.
Pageof 60